Published On: 10/29/2024
DIA RWE 2024 Research: Presentation by David Pritchard, PhD
Target RWE Director of Data Management & Statistics, David Pritchard, PhD, recently provided an insightful video preview of his presentation at the DIA Real-World Evidence (RWE) Conference titled 'Making the Case for Negative Control Outcome Studies in a Real-World Evidence Setting.' In this session, Dr. Pritchard delves into using Negative Control Outcome studies (NCOs) as a methodological approach to ensure robust treatment group comparability, ultimately strengthening study validity and reliability in real-world research settings.
Watch the video below to gain a deeper understanding of how NCO studies can enhance the accuracy of your research, reduce bias, and elevate the overall quality of your study findings.
About Target RWE
Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.
Visit our website to learn more: https://targetrwe.com/
Contact:
Kayla Slake
Senior Manager, Marketing
984.234.0268 ext 205
More News
-
01/31/2025
Maximizing the Value of Real-World Data: The Critical Role of Causal Inference in Pharmaceutical Innovation -
01/07/2025
Highlander Health Announces Inaugural Investment of Target RWE -
12/11/2024
New Patient-Reported Outcome Insights from Target RWE: NASH-CHECK Reveals Stability Over Time and Worse Scores Among Those with Decompensated Cirrhosis of Patients with MASLD -
12/04/2024
The Liver Meeting 2024 Research: Cirrhosis Presentation by Arun J. Sanyal, MBBS, MD -
12/04/2024
The Liver Meeting 2024 Research: NASH-CHECK Presentation by Arun J. Sanyal, MBBS, MD